Journal Mobile Options
Table of Contents
Vol. 75, No. 5, 2008
Issue release date: October 2008
Section title: Original Paper
Pathobiology 2008;75:274–280
(DOI:10.1159/000151707)

EphB1 Is Underexpressed in Poorly Differentiated Colorectal Cancers

Sheng Z.a · Wang J.a, b · Dong Y.a · Ma H.a · Zhou H.a · Sugimura H.c · Lu G.b · Zhou X.a
aDepartment of Pathology, Clinical School of Medical College of Nanjing University/Nanjing Jinling Hospital, and bCenter for Molecular Imaging Research, Department of Radiology, Nanjing Jinling Hospital, Nanjing, PR China; cDepartment of Pathology, Hamamatsu University School of Medicine, Hamamatsu, Japan
email Corresponding Author

Xiaojun Zhou, MD, PhD

Department of Pathology

Nanjing University School of Medicine/Nanjing Jinling Hospital

Nanjing 210002 (PR China)

Tel. +86 25 8086 1292, Fax +86 25 8086 0191, E-Mail nanjing_81@yahoo.com


References

  1. Hirai H, Maru Y, Hagiwara K, Nishida J, Takaku F: A novel putative tyrosine kinase receptor encoded by the eph gene. Science 1987;238:1717–1720.
  2. Unified nomenclature for Eph family receptors and their ligands, the ephrins. Eph Nomenclature Committee. Cell 1997;90:403–404.
  3. Kojima T, Chang JH, Azar DT: Proangiogenic role of ephrinB1/EphB1 in basic fibroblast growth factor-induced corneal angiogenesis. Am J Pathol 2007;170:764–773.
  4. Chumley MJ, Catchpole T, Silvany RE, Kernie SG, Henkemeyer M: EphB receptors regulate stem/progenitor cell proliferation, migration, and polarity during hippocampal neurogenesis. J Neurosci 2007;27:13481–13490.
  5. Kadison SR, Makinen T, Klein R, Henkemeyer M, Kaprielian Z: EphB receptors and ephrin-B3 regulate axon guidance at the ventral midline of the embryonic mouse spinal cord. J Neurosci 2006;26:8909–8914.
  6. Jevince AR, Kadison SR, Pittman AJ, Chien CB, Kaprielian Z: Distribution of EphB receptors and ephrin-B1 in the developing vertebrate spinal cord. J Comp Neurol 2006;497:734–750.
  7. Gerety SS, Anderson DJ: Cardiovascular ephrinB2 function is essential for embryonic angiogenesis. Development 2002;129:1397–1410.
  8. Wang J, Kataoka H, Suzuki M, Sato N, Nakamura R, Tao H, Maruyama K, Isogaki J, Kanaoka S, Ihara M, Tanaka M, Kanamori M, Nakamura T, Shinmura K, Sugimura H: Downregulation of EphA7 by hypermethylation in colorectal cancer. Oncogene 2005;24:5637–5647.
  9. Wang J, Li G, Ma H, Bao Y, Wang X, Zhou H, Sheng Z, Sugimura H, Jin J, Zhou X: Differential expression of EphA7 receptor tyrosine kinase in gastric carcinoma. Hum Pathol 2007;38:1649–1656.
  10. Cortina C, Palomo-Ponce S, Iglesias M, Fernandez-Masip JL, Vivancos A, Whissell G, Huma M, Peiro N, Gallego L, Jonkheer S, Davy A, Lloreta J, Sancho E, Batlle E: EphB-ephrin-B interactions suppress colorectal cancer progression by compartmentalizing tumor cells. Nat Genet 2007;39:1376–1383.
  11. Holmberg J, Genander M, Halford MM, Anneren C, Sondell M, Chumley MJ, Silvany RE, Henkemeyer M, Frisen J: EphB receptors coordinate migration and proliferation in the intestinal stem cell niche. Cell 2006;125:1151–1163.
  12. Batlle E, Henderson JT, Beghtel H, van den Born MM, Sancho E, Huls G, Meeldijk J, Robertson J, van de Wetering M, Pawson T, Clevers H: β-Catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB. Cell 2002;111:251–263.
  13. Clark SJ, Harrison J, Paul CL, Frommer M: High sensitivity mapping of methylated cytosines. Nucleic Acids Res 1994;22:2990–2997.
  14. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB: Methylation-specific PCR: a novel PCR assay for methylation status of CPG islands. Proc Natl Acad Sci USA 1996;93:9821–9826.
  15. Batlle E, Bacani J, Begthel H, Jonkheer S, Gregorieff A, van de Born M, Malats N, Sancho E, Boon E, Pawson T, Gallinger S, Pals S, Clevers H: EphB receptor activity suppresses colorectal cancer progression. Nature 2005;435:1126–1130.
  16. Davalos V, Dopeso H, Castano J, Wilson AJ, Vilardell F, Romero-Gimenez J, Espin E, Armengol M, Capella G, Mariadason JM, Aaltonen LA, Schwartz S Jr, Arango D: EphB4 and survival of colorectal cancer patients. Cancer Res 2006;66:8943–8948.
  17. Jubb AM, Zhong F, Bheddah S, Grabsch HI, Frantz GD, Mueller W, Kavi V, Quirke P, Polakis P, Koeppen H: EphB2 is a prognostic factor in colorectal cancer. Clin Cancer Res 2005;11:5181–5187.